IMMUNIC ($IMUX) posted quarterly earnings results for Q1 2026 on Wednesday, May 13th. The company reported earnings of -$1.08 per share, missing estimates of -$0.93 by $0.15. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $IMUX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
IMMUNIC Hedge Fund Activity
We have seen 27 institutional investors add shares of IMMUNIC stock to their portfolio, and 33 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ABERDEEN GROUP PLC removed 7,419,547 shares (-90.0%) from their portfolio in Q1 2026, for an estimated $82,356,971
- NANTAHALA CAPITAL MANAGEMENT, LLC added 4,378,406 shares (+inf%) to their portfolio in Q4 2025, for an estimated $2,336,755
- MILLENNIUM MANAGEMENT LLC added 2,888,829 shares (+544.6%) to their portfolio in Q4 2025, for an estimated $1,541,768
- LAURION CAPITAL MANAGEMENT LP added 2,000,000 shares (+106.3%) to their portfolio in Q4 2025, for an estimated $1,067,400
- SOLEUS CAPITAL MANAGEMENT, L.P. removed 1,580,007 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $843,249
- MORGAN STANLEY removed 1,012,111 shares (-32.6%) from their portfolio in Q4 2025, for an estimated $540,163
- VANGUARD GROUP INC added 675,232 shares (+15.5%) to their portfolio in Q4 2025, for an estimated $360,371
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
IMMUNIC Price Targets
Multiple analysts have issued price targets for $IMUX recently. We have seen 4 analysts offer price targets for $IMUX in the last 6 months, with a median target of $4.5.
Here are some recent targets:
- Matthew Caufield from HC Wainwright & Co. set a target price of $5.0 on 04/30/2026
- Paul Matteis from Stifel set a target price of $2.5 on 04/17/2026
- Yatin Suneja from Guggenheim set a target price of $7.0 on 03/24/2026
- Jason Kolbert from D. Boral Capital set a target price of $4.0 on 02/13/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
